119 related articles for article (PubMed ID: 6849401)
1. Intrarenal blood flow distribution during adenosine-mediated vasoconstriction.
Macias JF; Fiksen-Olsen M; Romero JC; Knox FG
Am J Physiol; 1983 Jan; 244(1):H138-41. PubMed ID: 6849401
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
Callis JT; Kuan CJ; Branch KR; Abels BC; Sabra R; Jackson EK; Branch RA
J Pharmacol Exp Ther; 1989 Mar; 248(3):1123-9. PubMed ID: 2703965
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
4. Species differences in renal vascular effects of dipyridamole and in the potentiation of adenosine action by dipyridamole.
Sakai K; Aono J; Haruta K
J Cardiovasc Pharmacol; 1981; 3(3):420-30. PubMed ID: 6168824
[TBL] [Abstract][Full Text] [Related]
5. Influence of plasma renin content, intrarenal angiotensin II, captopril, and calcium channel blockers on the vasoconstriction and renin release promoted by adenosine in the kidney.
Macias-Nuñez JF; García-Iglesias C; Santos JC; Sanz E; López-Novoa JM
J Lab Clin Med; 1985 Nov; 106(5):562-7. PubMed ID: 3903010
[TBL] [Abstract][Full Text] [Related]
6. Effect of allopurinol on the renovascular responses to adenosine.
Macias-Nunez JF; Revert M; Fiksen-Olsen M; Knox FG; Romero JC
J Lab Clin Med; 1986 Jul; 108(1):30-6. PubMed ID: 3519811
[TBL] [Abstract][Full Text] [Related]
7. Role of NO and COX pathways in mediation of adenosine A1 receptor-induced renal vasoconstriction.
Walkowska A; Dobrowolski L; Kompanowska-Jezierska E; Sadowski J
Exp Biol Med (Maywood); 2007 May; 232(5):690-4. PubMed ID: 17463166
[TBL] [Abstract][Full Text] [Related]
8. Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.
Deray G; Sabra R; Herzer WA; Jackson EK; Branch RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):631-5. PubMed ID: 2179530
[TBL] [Abstract][Full Text] [Related]
9. Effects of adenosine on adrenergically induced renal vasoconstriction in dogs.
Yoneda H; Hisa H; Satoh S
Eur J Pharmacol; 1990 Feb; 176(2):109-16. PubMed ID: 2311662
[TBL] [Abstract][Full Text] [Related]
10. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine.
Di Giantomasso D; Morimatsu H; May CN; Bellomo R
Crit Care Med; 2003 Oct; 31(10):2509-13. PubMed ID: 14530759
[TBL] [Abstract][Full Text] [Related]
11. Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline.
Gerkens JF; Heidemann HT; Jackson EK; Branch RA
J Pharmacol Exp Ther; 1983 Jun; 225(3):611-5. PubMed ID: 6864522
[TBL] [Abstract][Full Text] [Related]
12. Distribution of blood flow in the dog kidney. III. Local uptake of 10 mum and 15 mum microspheres during renal vasodilation and constriction.
Clausen G; Tyssebotn I; Kirkebø A; Ofjord ES; Aukland K
Acta Physiol Scand; 1981 Dec; 113(4):471-9. PubMed ID: 7348032
[TBL] [Abstract][Full Text] [Related]
13. Renal hemodynamic effects of exogenously administered adenosine and polyadenylic acid.
Thompson CI; Spielman WS
Am J Physiol; 1992 Nov; 263(5 Pt 2):F816-23. PubMed ID: 1443173
[TBL] [Abstract][Full Text] [Related]
14. Preferential inhibitory effect of nifedipine on angiotensin II-induced renal vasoconstriction.
Imagawa J; Kusaba-Suzuki M; Satoh S
Hypertension; 1986 Oct; 8(10):897-903. PubMed ID: 3531005
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
[TBL] [Abstract][Full Text] [Related]
16. Effects of C-type natriuretic peptide on renal vasoconstriction in dogs.
Yoshida K; Yamagata T; Tomura Y; Suzuki-Kusaba M; Yoshida M; Hisa H; Satoh S
Eur J Pharmacol; 1997 Nov; 338(2):131-4. PubMed ID: 9455994
[TBL] [Abstract][Full Text] [Related]
17. Systemic vasoconstrictor and renal vasodilator effects of PLV-2 (octapressin) in man.
Cohn JN; Tristani FE; Khatri IM
Circulation; 1968 Jul; 38(1):151-7. PubMed ID: 11712284
[TBL] [Abstract][Full Text] [Related]
18. Effect of renal vasodilatation on intrarenal blood flow distribution.
Rosivall L; Fazekas A; Pósch E; Szabó G; Hársing L
Acta Physiol Acad Sci Hung; 1979; 53(4):399-408. PubMed ID: 546041
[TBL] [Abstract][Full Text] [Related]
19. Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow.
Agmon Y; Dinour D; Brezis M
Am J Physiol; 1993 Dec; 265(6 Pt 2):F802-6. PubMed ID: 8285213
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
Handa RK; Strandhoy JW; Buckalew VM
Am J Physiol; 1991 Jul; 261(1 Pt 2):F108-16. PubMed ID: 1907104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
